旧金山湾区的小伙伴有福了 2024 SDDS on April 29-30

[Tlexander]

The 2024 Stanford Drug Discovery Symposium (2024 SDDS) is coming up on April 29-30,

[Tlexander]

George Addona, PhD - Senior VP and Head of Discovery, Preclinical Development, and Translational Medicine, Merck

Sharon Barr, PhD - SVP Biotherapeutics R&D, AstraZeneca

Hal Barron, MD - CEO and Founder, Atlas Labs

Carolyn Bertozzi, PhD - Anne T. and Robert M. Bass Professor, Stanford University

Paul Biondi, MBA - Executive Partner and President of Pioneering Medicine, Flagship Pioneering

Catherine Boileau, PhD, PharmD - Emeritus Professor of Genetics, Medical School of Paris Cité University

Paul Burton, MD, PhD - Chief Medical Officer, Amgen

Rob Califf, MD - Commissioner of Food and Drugs, FDA

Rosa Canet-Avilés, PhD - Vice President, Scientific Programs & Education, CIRM

Patrizia Cavazzoni, MD - Director of the Center for Drug Evaluation and Research (CDER), FDA

Don Cleveland, PhD - Department Chair and Professor, Cellular and Molecular Medicine, UCSJ

Marianne De Backer, M.Sc., MBA, MD - CEO and Director, VIR Biotechnology

Michael Devoy, MD - CMO of Bayer and EVP Medical Affairs & Pharmacovigilance for the Pharmaceuticals Division, Bayer

Paulo Fontoura, MD, PhD - Global Head and SVP of Neuroscience, Immunology, Ophthalmology, and Rare Diseases, Roche

Julie Grant, MBA, MPhil - General Partner, Canaan

Aida Habtezion, MD - CMO and Head of Worldwide Medical & Safety, Pfizer

Helen Hobbs, MD - Philip O'Bryan Montgomery Jr., MD, Distinguished Chair in Developmental Biology; Eugene McDermott Distinguished Chair for the Study of Human Growth and Development, UT Southwestern Medical Center

Karin Immergluck, PhD - Director, Stanford Office of Technology and Licensing

Joe Jimenez, MBA - Co-Founder and Managing Director, Arturine Bio

Karin Kleinhans, MSc, PhD - Partner, Life Ventures Fund

Hallie Kuhn, PhD - Senior Vice President, Alexandria Venture Investments

Michelle Longmire, MD - Co-Founder and CEO, Medable, Inc.

Thomas Lynch, MD - President and Director, Fred Hutchinson Cancer Research Center

Fady Malik, MD, PhD - Executive Vice President of Research & Development, Cytokineticss

Mathai Mammen, MD, PhD - CED, President, and Chairman, FogPharma

Peter Marks, MD, PhD - Director, Center for Biologics Evaluation and Research (CBER), FDA

Flavius Martin, MD - Executive Vice President of Research, Gilead Sciences

Lloyd Minor, MD - Carl and Elizabeth Naumann Professor and Vice Dean for Education, Stanford School of Medicine

Deep Nishar, MBA - Managing Director, General Catalyst

Yevgeniya Nusinovich, MD, PhD - Science Editor, Science Magazine

Robert Plenge, MD, PhD - Executive Vice President, Chief Research Officer, Head of Research Bristol Myers Squibb

Joni Rutter, PhD - Director, National Center for Advancing Translational Sciences (NCATS), NIH

Camille Samuels, MBA - Partner, Venrock

Wade Shen - Director of Proactive Health Office, APHA-H

Abhishek Shukla - Managing Director, Prosperity7Ventures

Daniel Skovronsky, MD, PhD - CSO and President, Lilly Research Labs; President, Immunology, Eli Lilly and Co.

Andrew Trister, MD, PhD - CMO and CSO, Verily Life Sciences

Andrea van Elsas, PhD - Partner, Third Rock Ventures

Gregory Verdine, PhD - Erving Professor of Chemistry, Harvard University

Michelle Williams, ScD - Dean and Mallinckrodt Professor of Epidemiology and Public Health, Harvard University

Bei Zhang, PhD - Corporate Vice President, Novo Nordisk